论文信息 - Small Molecule Therapeutics The Novel VEGF Receptor / MET – Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Pro fi le - 字舞流文

Small Molecule Therapeutics The Novel VEGF Receptor / MET – Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Pro fi le

Masanori Kato | Kimihiro Ito | S. Ito | Y. Aoyagi | T. Takenaka | K. Miyadera | Takamasa Suzuki | H. Ochiiwa | A. Hashimoto | H. Fujita | Y. Fujioka | H. Kazuno | Jinhong Huang | T. Suefuji | KosukeEgami | YoshimitsuSuda | KazutoNishio | andKazuhikoYonekura